Bachem Holding AG (SWX:BANB)

Market Cap	3.82B
Revenue (ttm)	677.93M
Net Income (ttm)	134.19M
Shares Out	74.97M
EPS (ttm)	1.80
PE Ratio	28.36
Forward PE	26.45
Dividend	0.85 (1.67%)
Ex-Dividend Date	May 5, 2025

Volume	51,563
Average Volume	117,636
Open	51.70
Previous Close	50.95
Day's Range	50.95 - 52.05
52-Week Range	43.34 - 77.60
Beta	1.00
RSI	31.00
Earnings Date	Mar 12, 2026

About Bachem Holding AG

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, an...

• Industry: Chemicals
• Sector: Materials
• Founded: 1971
• Employees: 2,207
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: BANB

Financial Performance

In 2024, Bachem Holding AG's revenue was 605.26 million, an increase of 4.84% compared to the previous year's 577.32 million. Earnings were 120.25 million, an increase of 7.50%.